Your browser doesn't support javascript.
loading
[Value of stem cell therapy for the treatment of stress incontinence. Current status and perspectives]. / Stellenwert der Stammzelltherapie für die Behandlung der Belastungsinkontinenz. Aktueller Stand und Ausblick.
Sievert, K-D; Amend, B; Renninger, M; Selent, C; Feil, G; Hennenlotter, J; Skutella, T; Möhle, R; Northoff, H; Stenzl, A.
Afiliação
  • Sievert KD; Klinik für Urologie, Universitätsklinikum, Hoppe-Seyler-Strasse 2, 72076, Tübingen, Deutschland. Karl.Sievert@med.uni-tuebingen.de
Urologe A ; 46(3): 264-7, 2007 Mar.
Article em De | MEDLINE | ID: mdl-17294151
ABSTRACT
Parallel to a fundamental change in the therapeutic approach to managing stress incontinence, an increasing number of patients ask for reconstruction of the outer, striated urethral sphincter as therapy for urinary stress incontinence. Regenerative medicine is starting to offer solutions using stem cells as a part of oncological therapy or in reconstructive surgery. In addition to the many auspicious experimental approaches, one published study reports the effective therapeutic use of myogenic stem cells in urinary stress incontinent patients. Before this procedure is adopted into general clinical practice, further studies with validated evaluations and a sound legal basis are needed.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Procedimentos Cirúrgicos Urológicos Masculinos / Incontinência Urinária por Estresse / Padrões de Prática Médica / Transplante de Células-Tronco / Medicina Regenerativa Limite: Humans / Male Idioma: De Revista: Urologe A Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Procedimentos Cirúrgicos Urológicos Masculinos / Incontinência Urinária por Estresse / Padrões de Prática Médica / Transplante de Células-Tronco / Medicina Regenerativa Limite: Humans / Male Idioma: De Revista: Urologe A Ano de publicação: 2007 Tipo de documento: Article